The adjuvant activity of AM3 (Inmunoferon®) to hepatitis B vaccination in haemodialysis patients is due to its ability to restore the innate as well as the specific immune responses.

被引：0
|
作者：
Reyes, E
Prieto, A
Monserrat, J
Villarrubia, V
Alvarez-Mon, M
机构：
[1] Univ Alcala de Henares, Dept Med, Madrid, Spain
[2] Ind Farmaceut Cantabria, Dept Immunol, Madrid, Spain
[3] Univ Alcala de Henares, Hosp Principe Asturias, Dept Med, Serv Immune Syst Dis & Oncol, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
833
引用
收藏
页码：371A / 371A
页数：1
相关论文
共 3 条
  • [1] The adjuvant activity of AM3 (Inmunoferon®) to hepatitis B (HBV) vaccination in haemodialysis patients is due to its ability to restore the innate as well as the adaptative immunity
    Reyes, E
    Prieto, A
    Monserrat, J
    Gonzalez, S
    Villarrubia, VG
    Alvarez-Mon, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 123 - 124
  • [2] AM3 (Inmunoferon®) as an adjuvant to hepatitis B vaccination in hemodialysis patients
    Pérez-García, R
    Pérez-García, A
    Verbeelen, D
    Bernstein, ED
    Villarrubia, VG
    Alvarez-Mon, M
    KIDNEY INTERNATIONAL, 2002, 61 (05) : 1845 - 1852
  • [3] AM3 administration appears to reverse the non-responder status to hepatitis B vaccination in haemodialysis (HD) patients.
    Jarillo, MD
    GarciaMartin, F
    Sada, G
    Calvo, CG
    Prieto, A
    Goni, M
    Villarubia, VG
    deMon, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2640 - A2640
1